GlobeNewswire

FutureWAN'18 Brings Industry Leaders Together for Global SD-WAN Summit

Dela

Amazon Web Services, IDC, Cisco and ServiceNow Among Featured Presenters

 

SAN JOSE, Calif., Jan. 18, 2018 (GLOBE NEWSWIRE) -- The FutureWAN'18 Summit today announced keynote presenters and the full agenda for its four day virtual summit. The global SD-WAN summit will feature analysts, technology providers, enterprise IT users and service providers. FutureWAN'18 will share experiences and deliver comprehensive education on the major aspects of enterprise WAN problems. Running Jan. 23 through Jan 26, the virtual event will feature multiple tracks, including Cloud, Security, Enterprise SD-WAN (Operations) and Managed Services.

SD-WAN's growth has created new and exciting growth opportunities for service providers and cloud players. The FutureWAN'18 summit will feature presentations by key players, including Verizon, BT, Orange Business Services and Amazon Web Services, among others, that are taking advantage of this new frontier. In addition, the summit will feature analyst presentations by IDC, Packet Pushers, Global Data, GestaltIT and EMA Research.

"Cloud adaption has made SD-WAN an important factor in network transformation decisions," stated Shamus McGillicuddy, Senior Analyst at EMA. "Enterprises require a modernized, cloud-ready infrastructure on which to roll out the new applications with enterprise-wide monitoring and control. SD-WAN delivers on many of those requirements." 

"Responding to the limitations of traditional WAN architectures and to the operational inefficiencies of legacy WAN management, software-defined WAN (SD-WAN) has struck a responsive chord with enterprises across a broad array of industries," said Brad Casemore, Research Director, Datacenter Networking at IDC. "Indeed, as the SD-WAN market moves into its next stage of robust growth - driven by mainstream enterprise adoption - IDC expects to see significant innovations during the next few years that will ensure that SD-WAN provides even greater value to enterprises worldwide."

The web-delivered summit is free for registered attendees. For a full schedule and to register visit: https://vshow.on24.com/vshow/sdwan/registration/14922

Summit Tracks: Jan. 23 - 26, 2018
Cloud Transformation

  • EMA Research: Establishing a Path to the Cloud-Ready Network with SD-WAN
  • Cisco: Solving Office 365 and SaaS Performance Issues with SD-WAN
  • Amazon Web Services: Extending VPCs with Cisco SD-WAN
  • Cisco: Speeding Amazon Web Services/Azure Migrations with SD-WAN
  • SD-WAN Demo: Application SLA Policies, Public Cloud and SaaS

Enterprise SD-WAN

  • Voice of the Customer: Retail Store Transformation with SD-WAN
  • ServiceNow: Delivering Efficient Service Management Capabilities with SD-WAN Alarms
  • Packet Pushers: State of SD-WAN, Q&A
  • Cisco: What to Ask Your Vendor - The Essential SD-WAN Capabilities?
  • SD-WAN Demo: Stepwise Migration from MPLS to Hybrid

Security and Branch Services

  • Voice of the Customer: Healthcare Transformation with SD-WAN
  • IDC: The Next Wave of SD-WAN Transformation, Research and Predictions
  • GestaltIT: Network Architect Roundtable: Best Practices on SD-WAN Migration
  • Cisco: Securing Branches with Secure Internet Gateways (SIG) and SD-WAN
  • SD-WAN Demo: Segmentation, the Most Implemented SD-WAN Feature

Managed Services

  • BT: Enabling Global Digital Transformation
  • Global Data: Managing Service Up the Value Chain with SD-WAN
  • Verizon: Case Studies in Managed SD-WAN Deployments
  • Orange Business Services: Speeding Transformation with Managed SD-WAN

About FutureWAN'18
FutureWAN'18 brings together network architects, industry analysts, telecom carriers and leading technology providers to discuss the next wave of SD-WAN deployments. The four day virtual summit will feature four tracks: enterprise SD-WAN, security and branch services, cloud transformation and managed services. Speakers will provide a comprehensive industry view on the requirements, best practices and lessons learned in migrating to SD-WAN. The views and opinions expressed by the speakers who are not employed by Cisco or associated with Cisco do not represent or reflect the views of Cisco or Cisco's affiliates. For more information, visit https://vshow.on24.com/vshow/sdwan/registration/14922.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/cc848d32-247c-4941-a868-b93d2a91861b

PR Contact:
Taylor Hassman
415-610-6075
thassman@cisco.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cisco via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Stillfront: Simutronics reclaims publishing services10.12.2018 14:11Pressmeddelande

PRESS RELEASE December 10, 2018 Simutronics reclaims the publishing services for SIEGE: Titan Wars globally except China Simutronics Corp, a studio within Stillfront Group AB, has ended a co-publishing agreement regarding the mobile game SIEGE: Titan Wars with New York based publishing partner Tilting Point. According to a new agreement, Tilting Point will continue to provide publishing services and market the game in China but Simutronics will run the publishing services and marketing globally from the Group going forward. Simutronics is a leading developer of online roleplaying and mobile games such as DragonRealms, GemStone IV and Lara Croft Relic Run, the latter with more than 23 million downloads. Tilting Point is a new-generation games partner that provides top development studios with expert resources, services, and operational support to optimize high quality live games for success. "I am very pleased to continue the partnership with Tilting Point for the Chinese market as this

Stillfront: Simutronics återtar förläggartjänster10.12.2018 14:11Pressmeddelande

PRESSMEDDELANDE 2018-12-10 Simutronics återtar förläggartjänster för SIEGE: Titan Wars globalt med undantag för Kina Simutronics, en studio inom Stillfront Group, har avslutat ett medförläggaravtal avseende mobilspelet SIEGE: Titan Wars med den New York-baserade förläggarpartnern Tilting Point. Enligt ett nytt avtal kommer Tilting Point fortsatt att tillhandahålla förläggartjänster och marknadsföring av spelet i Kina men på global nivå kommer Simutronics att ansvara för förläggartjänster och marknadsföring av spelet från gruppen. Simutronics är en ledande utvecklare av rollspel och mobila spel som till exempel DragonRealms, GemStone IV och Lara Croft Relic Run, den sistnämnda med mer än 23 miljoner nedladdningar. Tilting Point är den nya generationens spelbolagspartner som förser ledande utvecklingsstudios med expertis, tjänster och operationell support för att optimera högkvalitativa livespel framgångsrikt. "Jag är mycket nöjd över det fortsatta partnerskapet med Tilting Point för den

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum